The Recent NTSB Mandatory Sleep Apnea Testing Recommendations Are Expected To Become A Law Very Soon For Commercial Pilots And Drivers. It's Reported That In Current Tracking Industry, A Sleep Apnea Lab Testing Could Cost About $2,000 With A Waiting Period Of Up To Six Months. More Than 60% Of Diagnosed Apnea Patients Can Not Tolerate Standard CPAP Treatment. Dr. Jin Zhou Of SleepApneaUSA.net Proposed An Immediate Alternative Solution In Hope To Save Thousands Of Lives.
Hanover Park, IL (PRWEB) November 6, 2009 -- The recent NTSB mandatory recommendations for sleep apnea testing and treatment are expected to become a law very soon for commercial pilots and drivers due to the eminent public safety and tort liability litigation concerns. It's reported that in the current tracking industry, a sleep apnea lab testing could cost about $2,000 with a waiting period of up to six months. More than 60% of diagnosed apnea patients can not tolerate standard CPAP Treatment. Dr. Jin Zhou of SleepApneaUSA.net proposed an immediate alternative solution in hope to save thousands of lives, before the next pilot and driver can be tested in a standard lab, because it is well known that a driver with sleep apnea is much more dangerous than a drunk driver with DUI risk factors. Dr. Zhou proposed, to the government and the public, that all commercial pilots and drivers to be immediately tested for sleep apnea screening with a portable home sleep apnea test device, costing only about $500, that is FDA cleared, Medicare and FMCSA accepted, and that those with positive apnea results should be re-tested in a standard sleep lab and be treated immediately under standard medical programs with CPAP or surgery if indicated. In addition, Dr. Zhou offered an immediate alternative sleep apnea solution, ZHT (Zhou's Hypoxicology Therapy) for more than 60% of sleep apnea positive pilots and drivers who cannot tolerate CPAP and not indicated for surgery, and for those who have CPAP tolerance and compliance with satisfactory results but prefer to live a lifestyle without a lifetime sleeping mask. Last week, Dr. Zhou announced ZHT Certification training class schedules for 2010 in Chicago for healthcare providers after more than 20 years of clinical research and four years of ZHT clinical training for healthcare providers nationwide.
Under ZHT Sleep Apnea Protocol, a patient is expected to see definitive noticeable results on the first visit, significant and satisfactory results within three sessions or ZHT therapy should be discontinued. Generally speaking, a patient with mild sleep apnea is expected to be well-controlled or with apnea eliminated within one month, moderate sleep apnea within two months, and severe sleep apnea within three months or longer for some cases. ZHT Certification Training Program is only available to healthcare providers in any types and specialties. Dr. Zhou hopes that his ZHT sleep apnea programs will ensure that NTSB's sleep apnea recommendations are practically implementable for immediate public safety, and ZHT shall only be an alternative solution in addition to standard medical practice without any conflict.
The NTSB made the same sleep apnea recommendations indirectly to the Coast Guard. "Actually, the NTSB sleep apnea recommendation should be scientifically correct and practically more important, as our national security, to all U.S. military pilots and combat personnel, after reported death of a soldier due to inoperable CPAP in Iraq", said Dr. Jin Zhou, a former orthopedic surgeon with the China Air Force General Hospital in Beijing, China 21 years ago. Today, a new report indicated that 75% of young Americans are unfit for military service, mostly due to physical problems rather than criminal history and lack of education. Exercise-induced asthma, strength and endurance deficiency as well as obesity are directly related to undiagnosed sleep apnea. We have been clearly warned by the avalanche amount of new reports on sleep apnea caused illness and disabilities from active military personnel and military veterans. The most long-term disability claims litigated in federal court were ultimately resulted from the illness caused by undiagnosed sleep apnea, according to Dr. Jin Zhou, who is also an ERISA expert.
Sleep apnea is a deadly illness if without timely diagnosis and proper treatment, however, the current standard medical treatments are only focused on the surgeries and expensive, lifetime devices, with very limited clinical results and they are only for less than 30% of the sleep apnea population.
It was estimated that more than 95-97% of sleep apnea sufferers were never diagnosed. Even for those patients already diagnosed with sleep apnea, it was reported that only less than 20% of them have good tolerance and compliance with the prescribed gold CPAP therapy, and more than 60% to 80% of patients already diagnosed with sleep apnea have no or poor tolerance with or benefit from the standard medical treatment with CPAP or surgery.
It is now reasonably well-known and established that sleep apnea has been linked to most of the CDC's top 10 death-cause medical conditions, such as heart attack, cancer, stroke and diabetes. However, the original or ultimate cause for sleep apnea is not clearly known at all to the scientists and health care practitioners. Dr. Jin Zhou challenges the popular or mainstream theory in etiology for the sleep apnea that obstruction or collapse of the upper airway is due to the weakened and enlarged soft palate. As a matter of fact, as Dr. Jin Zhou hypothesized, the clinical reality is the exact opposite or completely different, therefore the current mainstream clinical treatment protocols by surgery and CPAP or oral devices are not expected to ultimately cure sleep apnea but simply to provide for some limited or short-term relief or temporarily cover up the deterioration of sleep apnea development.
In developing the new ZHT (Zhou's Hypoxicology Therapy) treatment of sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development. Dr. Zhou further hypothesized that all of these sleep apnea etiological components are primarily controlled or regulated internally by the human body but induced externally. Therefore, sleep apnea should be completely reversible primarily through volitional resuscitation, resetting of the baroreflex and revitalization of the upper airway defense reflex by working through patient's body internally instead of externally through surgeries and devices.
ZHT, Zhou's Hypoxicology Therapy, as pioneered by its creator, Dr. Jin Zhou, is a new scientific concept and pioneering (aka, unproven) clinical solution as an alternative approach for sleep apnea. ZHT was noticed to be clinically beneficial not only to those sleep apnea patients but also to those patients with commonly seen medical conditions, from headache to sciatica, and mysteriously hard to treat medical conditions as a result of hypoxia, baroreflex dysfunction and dysautonomia.
Dr. Jin Zhou, D.C., M.D. (China), a former orthopedic surgeon 21 years ago in China and currently a licensed chiropractic physician in Illinois for the last 18 years, is dedicated to developing a revolutionary breakthrough, an extremely simple and super natural therapy that could potentially save millions of lives and trillions of dollars without having to rely upon only medication, surgery and device. He coined the new word, "Hypoxicology". Dr. Zhou is also a nationally renowned expert in healthcare compliance and reimbursement. Dr. Jin Zhou is the president of ERISAclaim.com.
For more information, please visit http://sleepapneausa.net/ZHT_Certifcation.htm, or contact Dr. Jin Zhou at 630-808-7237.
Read the full story at http://www.prweb.com/releases/2009/11/prweb3167634.htm.
Copyright©2009 Vocus, Inc.
All rights reserved